Determining the ideal retatrutide regimen is critically necessary for obtaining best results . Initially, patients typically start with a modest amount of around 2.4 mg, administered each week via subcutaneous . This starting quantity is then gradually increased every four weeks , up to a highest amount of 10.8 mg, according to person reaction and